Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis

Journal of the American Society of Nephrology

Volumn 26, Issue 11, 2015, Pages 2800-2814

  Scindia, Yogesh ^a   Dey, Paromita ^a   Thirunagari, Abhinav ^a   Liping, Huang ^a   Rosin, Diane L ^a   Floris, Matteo ^a,b   Okusa, Mark D ^a   Swaminathan, Sundararaman ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b BROTZU HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FERROPORTIN; HEPCIDIN; INTERLEUKIN 6; IRON; CD45 ANTIGEN; INTERLEUKIN-6, MOUSE; PTPRC PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HOMEOSTASIS; IRON BLOOD LEVEL; IRON DEPLETION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; ACUTE KIDNEY FAILURE; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; INFLAMMATION; KIDNEY; MALE; METABOLISM; PATHOLOGY; SPLEEN; TRANSGENIC MOUSE; TUNEL ASSAY;

ACUTE KIDNEY INJURY; ANIMALS; ANTIGENS, CD45; APOPTOSIS; GENE EXPRESSION REGULATION; HEPCIDINS; HOMEOSTASIS; IN SITU NICK-END LABELING; INFLAMMATION; INTERLEUKIN-6; IRON; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; OXIDATIVE STRESS; REPERFUSION INJURY; SPLEEN;

EID: 84937979950     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014101037     Document Type: Article

References (65)

1. Bagshaw SM: The long-term outcome after acute renal failure. Curr Opin Crit Care 12: 561-566, 2006
2. Korkeila M, Ruokonen E, Takala J: Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 26: 1824-1831, 2000
3. Devarajan P: Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr 17: 193-199, 2005
4. Dagher PC, Herget-Rosenthal S, Ruehm SG, Jo SK, Star RA, Agarwal R, Molitoris BA: Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol 14: 2188-2198, 2003
5. Li C, Jackson RM: Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol 282: C227-C241, 2002
6. Friedewald JJ, Rabb H: Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-491, 2004
7. Baliga R, Ueda N, Shah SV: Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J 291: 901-905, 1993
8. Voogd A, Sluiter W, van Eijk HG, Koster JF: Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest 90: 2050 2055, 1992
9. Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P: Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury. Transplantation 76: 50-54, 2003
10. Hirakawa A, Takeyama N, Nakatani T, Tanaka T: Mitochondrial permeability transition and cytochrome c release in ischemiareperfusion injury of the rat liver. J Surg Res 111: 240-247, 2003
11. Aroun A, Zhong JL, Tyrrell RM, Pourzand C: Iron, oxidative stress and the example of solar ultraviolet A radiation. Photochem Photobiol Sci 11: 118-134, 2012
12. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV: Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int 54: 1562-1569, 1998
13. Zhang W, Wang M, Xie HY, Zhou L, Meng XQ, Shi J, Zheng S: Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation. Transplant Proc 39: 1332-1337, 2007
14. Himmelfarb J,McMonagle E, Freedman S, Klenzak J,McMenamin E, Le P, Pupim LB, Ikizler TA; The PICARD Group: Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15: 2449-2456, 2004
15. de Vries B, Walter SJ, von Bonsdorff L, Wolfs TG, van Heurn LW, Parkkinen J, BuurmanWA: Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation 77: 669-675, 2004
16. Baliga R, Zhang Z, Baliga M, Shah SV: Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 49: 362-369, 1996
17. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53: 394-401, 1998
18. Zager RA: Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 90: 711-719, 1992
19. Paller MS: Hemoglobin- and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol 255: F539-F544, 1988
20. Montalbetti N, Simonin A, Kovacs G, Hediger MA: Mammalian iron transporters: Families SLC11 and SLC40. Mol Aspects Med 34: 270 287, 2013
21. Abboud S, Haile DJ: A novel mammalian iron-regulated protein involved in intracellular ironmetabolism.JBiol Chem275: 19906-19912, 2000
22. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, SundquistWI, Ganz T, Musci G, Kaplan J: The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18: 2569-2578, 2007
23. Moulouel B, HouamelD,Delaby C, Tchernitchko D, Vaulont S, Letteron P, Thibaudeau O, Puy H, Gouya L, Beaumont C, Karim Z: Hepcidin regulates intrarenal iron handling at the distal nephron. Kidney Int 84: 756-766, 2013
24. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810, 2001
25. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004
26. Nemeth E: Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol 2010: 750643, 2010
27. De Domenico I, Ward DM, Kaplan J: Hepcidin regulation: Ironing out the details. J Clin Invest 117: 1755-1758, 2007
28. Izawa T, Murakami H, Wijesundera KK, Golbar HM, Kuwamura M, Yamate J: Inflammatory regulation of iron metabolism during thioacetamide-induced acute liver injury in rats. Exp Toxicol Pathol 66: 155-162, 2014
29. Maisetta G, Vitali A, Scorciapino MA, Rinaldi AC, Petruzzelli R, Brancatisano FL, Esin S, Stringaro A, Colone M, Luzi C, Bozzi A, Campa M, Batoni G: pH-dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25. FEBS J 280: 2842-2854, 2013
30. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW: Hepcidin in human iron disorders: Diagnostic implications. Clin Chem 57: 1650-1669, 2011
31. LiuQ, DavidoffO,Niss K,Haase VH: Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest 122: 4635-4644, 2012
32. Ho J, Reslerova M, Gali B, Gao A, Bestland J, Rush DN, Nickerson PW, Rigatto C: Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass. Clin J Am Soc Nephrol 6: 2340-2346, 2011
33. Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 80: 29-40, 2011
34. Chien CT, Chang TC, Tsai CY, Shyue SK, Lai MK: Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis. Am J Transplant 5: 1194-1203, 2005
35. Liang HL, Hilton G, Mortensen J, Regner K, Johnson CP, Nilakantan V: MnTMPyP, a cell-permeant SOD mimetic, reduces oxidative stress and apoptosis following renal ischemia-reperfusion. Am J Physiol Renal Physiol 296: F266-F276, 2009
36. Huang H, He Z, Roberts LJ 2nd, Salahudeen AK:Deferoxamine reduces cold-ischemic renal injury in a syngeneic kidney transplant model.AmJ Transplant 3: 1531-1537, 2003
37. Arkadopoulos N, Nastos C, Kalimeris K, Economou E, Theodoraki K, Kouskouni E, Pafiti A, Kostopanagiotou G, Smyrniotis V: Iron chelation for amelioration of liver ischemia-reperfusion injury. Hemoglobin 34: 265-277, 2010
38. Schneider MP, Sullivan JC,Wach PF, Boesen EI, Yamamoto T, Fukai T, Harrison DG, Pollock DM, Pollock JS: Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury. Kidney Int 78: 374-381, 2010
39. Liu W, Kato M, Akhand AA, Hayakawa A, Suzuki H, Miyata T, Kurokawa K, Hotta Y, Ishikawa N, Nakashima I: 4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J Cell Sci 113: 635-641, 2000
40. Chaturvedi S, Yuen DA, Bajwa A, Huang YW, Sokollik C, Huang L, Lam GY, Tole S, Liu GY, Pan J, Chan L, Sokolskyy Y, Puthia M, Godaly G, John R, Wang C, Lee WL, Brumell JH, Okusa MD, Robinson LA: Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury. J Am Soc Nephrol 24: 1274-1287, 2013
41. Kinsey GR, Li L, Okusa MD: Inflammation in acute kidney injury. Nephron Exp Nephrol 109: e102-e107, 2008
42. Berberat PO, Katori M, Kaczmarek E, Anselmo D, Lassman C, Ke B, Shen X, Busuttil RW, Yamashita K, Csizmadia E, Tyagi S, Otterbein LE, Brouard S, Tobiasch E, Bach FH, Kupiec-Weglinski JW, Soares MP: Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17: 1724-1726, 2003
43. Mandal AK, Miller J: Protection against ischemic acute renal failure by prostaglandin infusion. Prostaglandins Leukot Med 8: 361-373, 1982
44. Burne-Taney MJ, Liu M, Baldwin WM, Racusen L, Rabb H: Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol 176: 7015-7020, 2006
45. Gigliotti JC, Huang L, Ye H, Bajwa A, Chattrabhuti K, Lee S, Klibanov AL, Kalantari K, Rosin DL, Okusa MD: Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic antiinflammatory pathway. J Am Soc Nephrol 24: 1451-1460, 2013
46. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY: Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16: 3315-3325, 2005
47. Nechemia-Arbely Y, Barkan D, Pizov G, Shriki A, Rose-John S, Galun E, Axelrod JH: IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol 19: 1106-1115, 2008
48. Paller MS, Hedlund BE: Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation. Free Radic Biol Med 17: 597-603, 1994
49. Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15: 3073-3082, 2004
50. Zarjou A, Bolisetty S, Joseph R, Traylor A, Apostolov EO, Arosio P, Balla J, Verlander J, Darshan D, Kuhn LC, Agarwal A: Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest 123: 4423-4434, 2013
51. Bauminger ER, Harrison PM, Hechel D, Nowik I, Treffry A: Iron (III) can be transferred between ferritin molecules. Proc Biol Sci 244: 211-217, 1991
52. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149: 1060-1072, 2012
53. Golab F, Kadkhodaee M, ZahmatkeshM, HedayatiM, Arab H, Schuster R, Zahedi K, Lentsch AB, Soleimani M: Ischemic and non-ischemic acute kidney injury cause hepatic damage. Kidney Int 75: 783-792, 2009
54. Ganz T: Macrophages and systemic iron homeostasis. J Innate Immun 4: 446-453, 2012
55. Chaston T, Chung B,Mascarenhas M,Marks J, Patel B, Srai SK, Sharp P: Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut 57: 374-382, 2008
56. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM: Iron-independent induction of ferritinHchain by tumor necrosis factor. ProcNatl Acad Sci U S A 88: 4946-4950, 1991
57. Haase VH: Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 299: F1-F13, 2010
58. Yang F, Liu XB,QuinonesM,Melby PC, Ghio A, Haile DJ: Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 277: 39786-39791, 2002
59. Goss JA, Seu P, Gao FQ, Wyllie S: Ischemia-reperfusion of rat liver modulates hepcidin in vivo expression. Liver Transpl 11: 800-806, 2005
60. Lesbordes-Brion JC1, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, Hamard G, Kahn A, Vaulont S: Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108(4): 1402-1405, 2006
61. Anderson GJ, Ramm GA, Halliday JW, Powell LW: Ferritin metabolism in hemochromatosis. In: Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment, edited by Barton JC, Edwards CQ, Cambridge University Press, United Kingdom, 2000, pp 145-157
62. Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009: 137072, 2009
63. Wrighting DM, AndrewsNC: Interleukin-6 induces hepcidin expression through STAT3. Blood 108: 3204-3209, 2006
64. De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, Kaplan J: Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 120: 2395-2405, 2010
65. Torrance JD, Bothwell TH: Tissue iron stores. In: Iron: Methods in Hematology, edited by Cook J, New York, Churchill Livingstone, 1980, pp 90-115